We use cookies on our website to improve the website and your experience.
Read moreCommanders & Chiefs
05 May 2020"The role of chief technology officer has become more encompassing as companies adopt new software and technology-based solutions to solve some of their biggest challenges and create opportunities for new rewards."
Recently Albumedix' Chief Technology Officer, Phil Morton, contributed his thoughts on industry trends and the impact of evolving technology in a PharmaVoice feature focusing on ´Commanders & Chiefs.´
When reflecting on the biggest trends he's tracking in his role as Chief Technology Officer currently, Morton noted that within gene therapy, the move to better analytics is crucial to get a real understanding of the stability and efficacy of the viral vectors. While for cell therapies, extensions of cell stability and improvements in raw material consistency to reduce product variability are critical.
Follow the link below to access the full article and see how Mortons' opinions compare to other industry experts.
Read the article on the PharmaVoice website here
